Breath isoprene: Muscle dystrophy patients support the concept of a pool of isoprene in the periphery of the human body

Biochemical and Biophysical Research Communications

Volumn 423, Issue 3, 2012, Pages 526-530

  King, J ^a,b,c   Mochalski, P ^a,d   Unterkofler, K ^a,e   Teschl, G ^c   Klieber, M ^a,b   Stein, M ^f   Amann, A ^a,b   Baumann, M ^b  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d INSTITUTE OF NUCLEAR PHYSICS   (Poland)

^e VORARLBERG UNIVERSITY OF APPLIED SCIENCES   (Austria)

^f LKH Natters ^*  (Austria)

Author keywords

Duchenne muscular dystrophy; Exhaled breath analysis; Isoprene; Muscle

Indexed keywords

ISOPRENE;

ADULT; ARTICLE; BODY REGIONS; BREATH ANALYSIS; BREATHING; BREATHING MECHANICS; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; HUMAN; MALE; MUSCLE TISSUE; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; VENOUS BLOOD;

ADOLESCENT; BODY TEMPERATURE; BUTADIENES; COHORT STUDIES; FEMALE; HEMITERPENES; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; OXIDATIVE STRESS; PENTANES; RESPIRATION; YOUNG ADULT;

EID: 84863301037     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.159     Document Type: Article

References (41)

1. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring 2005, World Scientific, Singapore. A. Amann, D. Smith (Eds.).
2. King J., Kupferthaler A., Unterkofler K., Koc H., Teschl S., Teschl G., Miekisch W., Schubert J., Hinterhuber H., Amann A. Isoprene and acetone concentration profiles during exercise on an ergometer. J. Breath Res. 2009, 3:027006.
3. King J., Mochalski P., Kupferthaler A., Unterkofler K., Koc H., Filipiak W., Teschl S., Hinterhuber H., Amann A. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study. Physiol. Meas. 2010, 31:1169-1184.
4. King J., Unterkofler K., Teschl G., Teschl S., Koc H., Hinterhuber H., Amann A. A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone. J. Math. Biol. 2011, 63:959-999.
5. Kamysek S., Fuchs P., Schwoebel H., Roesner J.P., Kischkel S., Wolter K., Loeseken C., Schubert J.K., Miekisch W. Drug detection in breath: effects of pulmonary blood flow and cardiac output on propofol exhalation. Anal. Bioanal. Chem. 2011, 401:2093-2102.
6. King J., Unterkofler K., Teschl S., Amann A., Teschl G. Breath gas analysis for estimating physiological processes using anesthetic monitoring as a prototypic example. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. 2011, 1001-1004.
7. King J., Kupferthaler A., Frauscher B., Hackner H., Unterkofler K., Teschl G., Hinterhuber H., Amann A., Hoegl B. Measurement of endogenous acetone and isoprene in exhaled breath during sleep. Physiol. Meas. 2012, 33:413-428.
8. Beauchamp J., Kirsch F., Buettner A. Real-time breath gas analysis for pharmacokinetics: monitoring exhaled breath by on-line proton-transfer-reaction mass spectrometry after ingestion of eucalyptol-containing capsules. J. Breath Res. 2010, 4:026006.
9. Pleil J.D. Role of exhaled breath biomarkers in environmental health science. J. Toxicol. Environ. Health B Crit. Rev. 2008, 11:613-629.
10. Gelmont D., Stein R.A., Mead J.F. Isoprene - the main hydrocarbon in human breath. Biochem. Biophys. Res. Commun. 1981, 99:1456-1460.
11. Mochalski P., King J., Kupferthaler A., Unterkofler K., Hinterhuber H., Amann A. Measurement of isoprene solubility in water, human blood and plasma by multiple headspace extraction gas chromatography coupled with solid phase microextraction. J. Breath Res. 2011, 5:046010.
12. Salerno-Kennedy R., Cashman K.D. Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview. Wien. Klin. Wochenschr. 2005, 117:180-186.
13. Sharkey T.D., Wiberley A.E., Donohue A.R. Isoprene emission from plants: why and how. Ann. Bot. 2008, 101:5-18.
14. Kushch I., Arendacka B., Stolc S., Mochalski P., Filipiak W., Schwarz K., Schwentner L., Schmid A., Dzien A., Lechleitner M., Witkovsky V., Miekisch W., Schubert J., Unterkofler K., Amann A. Breath isoprene-aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study. Clin. Chem. Lab. Med. 2008, 46:1011-1018.
15. Deneris E.S., Stein R.A., Mead J.F. In vitro biosynthesis of isoprene from mevalonate utilizing a rat liver cytosolic fraction. Biochem. Biophys. Res. Commun. 1984, 123:691-696.
16. Sharkey T.D. Isoprene synthesis by plants and animals. Endeavour 1996, 20:74-78.
17. Vickers C.E., Gershenzon J., Lerdau M.T., Loreto F. A unified mechanism of action for volatile isoprenoids in plant abiotic stress. Nat. Chem. Biol. 2009, 5:283-291.
18. McGrath L.T., Patrick R., Silke B. Breath isoprene in patients with heart failure. Eur. J. Heart Fail. 2001, 3:423-427.
19. Amann A., Corradi M., Mazzone P., Mutti A. Lung cancer biomarkers in exhaled breath. Expert Rev. Mol. Diagn. 2011, 11:207-217.
20. Karl T., Prazeller P., Mayr D., Jordan A., Rieder J., Fall R., Lindinger W. Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. J. Appl. Physiol. 2001, 91:762-770.
21. King J., Koc H., Unterkofler K., Mochalski P., Kupferthaler A., Teschl G., Teschl S., Hinterhuber H., Amann A. Physiological modeling of isoprene dynamics in exhaled breath. J. Theor. Biol. 2010, 267:626-637.
22. Koc H., King J., Teschl G., Unterkofler K., Teschl S., Mochalski P., Hinterhuber H., Amann A. The role of mathematical modeling in VOC analysis using isoprene as a prototypic example. J. Breath Res. 2011, 5:037102.
23. Swinyard C.A., Deaver G.G., Greenspan L. Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. Arch. Phys. Med. Rehabil. 1957, 38:574-579.
24. Smith D., Spanel P., Enderby B., Lenney W., Turner C., Davies S.J. Isoprene levels in the exhaled breath of 200 healthy pupils within the age range 7-18 years studied using SIFT-MS. J. Breath Res. 2010, 4:017101.
25. van Beek E., Pieterman E., Cohen L., Löwik C., Papapoulos S. Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochem. Biophys. Res. Commun. 1999, 264:108-111.
26. Amann A., Miekisch W., Pleil J., Risby T., Schubert J. Methodological issues of sample collection and analysis of exhaled breath. Eur. Respir. Mon. 2010, 49:96-114.
27. Miekisch W., Schubert J.K., Vagts D.A., Geiger K. Analysis of volatile disease markers in blood. Clin. Chem. 2001, 47:1053-1060.
28. 2 retention in patients with neuromuscular disease. Chest 2000, 117:447-453.
29. O'Hara M.E., Clutton-Brock T.H., Green S., Mayhew C.A. Endogenous volatile organic compounds in breath and blood of healthy volunteers: examining breath analysis as a surrogate for blood measurements. J. Breath Res. 2009, 3:027005.
30. Cailleux A., Cogny M., Allain P. Blood isoprene concentrations in humans and in some animal species. Biochem. Med. Metab. Biol. 1992, 47:157-160.
31. Littarru G.P., Jones D., Scholler J., Folkers K. Deficiency of coenzyme Q9 in mice having hereditary muscular dystrophy. Biochem. Biophys. Res. Commun. 1970, 41:1306-1313.
32. Siciliano G., Mancuso M., Tedeschi D., Manca M.L., Renna M.R., Lombardi V., Rocchi A., Martelli F., Murri L. Coenzyme Q10, exercise lactate and CTG trinucleotide expansion in myotonic dystrophy. Brain Res. Bull. 2001, 56:405-410.
33. Morikawa S., Murakami T., Yamazaki H., Izumi A., Saito Y., Hamakubo T., Kodama T. Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins. J. Atheroscler. Thromb. 2005, 12:121-131.
34. Vaklavas C., Chatzizisis Y.S., Ziakas A., Zamboulis C., Giannoglou G.D. Molecular basis of statin-associated myopathy. Atherosclerosis 2009, 202:18-28.
35. Baker S.K. Molecular clues into the pathogenesis of statin-mediated muscle toxicity. Muscle Nerve 2005, 31:572-580.
36. Siwko M.E., Marrink S.J., de Vries A.H., Kozubek A., Schoot Uiterkamp A.J., Mark A.E. Does isoprene protect plant membranes from thermal shock? A molecular dynamics study. Biochim. Biophys. Acta 2007, 1768:198-206.
37. Ohvo-Rekila H., Ramstedt B., Leppimaki P., Slotte J.P. Cholesterol interactions with phospholipids in membranes. Prog. Lipid Res. 2002, 41:66-97.
38. Shack S., Gorospe M., Fawcett T.W., Hudgins W.R., Holbrook N.J. Activation of the cholesterol pathway and Ras maturation in response to stress. Oncogene 1999, 18:6021-6028.
39. Bentinger M., Tekle M., Dallner G. Coenzyme Q - biosynthesis and functions. Biochem. Biophys. Res. Commun. 2010, 396:74-79.
40. Stein R.A., Mead J.F. Small hydrocarbons formed by the peroxidation of squalene. Chem. Phys. Lipids 1988, 46:117-120.
41. Sen C.K. Oxidants and antioxidants in exercise. J. Appl. Physiol. 1995, 79:675-686.